Literature DB >> 1797442

Improvement of dissolution and bioavailability for mebendazole, an agent for human echinococcosis, by preparing solid dispersion with polyethylene glycol.

Y Chiba1, N Kohri, K Iseki, K Miyazaki.   

Abstract

The solid dispersion of mebendazole was prepared with polyethylene glycol (PEG) to enhance the dissolution rate of mebendazole, an agent for the chemotherapy of human echinococcosis. The dissolution rate of the solid dispersion increased compared with the physical mixture, and also increased with the incorporation of an increasing amount of PEG-6000. An extensive improvement of the dissolution rate was observed when the ratio of the solid dispersion of mebendazole to PEG-6000 was more than 1: 2. Furthermore, greater bioavailability in rabbits was obtained after oral administration of the solid dispersion compared with the physical mixture.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1797442     DOI: 10.1248/cpb.39.2158

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  5 in total

1.  Enhanced bioavailability and cysticidal effect of three mebendazole-oil preparations in mice infected with secondary cysts of Echinococcus granulosus.

Authors:  Cong-shan Liu; Hao-bing Zhang; Bin Jiang; Jun-min Yao; Yi Tao; Jian Xue; Ai-dan Wen
Journal:  Parasitol Res       Date:  2012-06-04       Impact factor: 2.289

2.  Effect of squalane on mebendazole-loaded Compritol® nanoparticles.

Authors:  Richard A Graves; Grace A Ledet; Cedric A Nation; Yashoda V Pramar; Levon A Bostanian; Tarun K Mandal
Journal:  J Biomater Sci Polym Ed       Date:  2015-07-09       Impact factor: 3.517

3.  Itraconazole nanosuspension for oral delivery: Formulation, characterization and in vitro comparison with marketed formulation.

Authors:  M Nakarani; A K Misra; J K Patel; S S Vaghani
Journal:  Daru       Date:  2010       Impact factor: 3.117

4.  An alternative mebendazole formulation for cystic echinococcosis: the treatment efficacy, pharmacokinetics and safety in mice.

Authors:  Cong-Shan Liu; Hao-Bing Zhang; Wen Lei; Chao-Wei Zhang; Bin Jiang; Qi Zheng; Jian-Hai Yin; Xiu-Min Han
Journal:  Parasit Vectors       Date:  2014-12-10       Impact factor: 3.876

5.  Repurposing Drugs in Oncology (ReDO)-mebendazole as an anti-cancer agent.

Authors:  Pan Pantziarka; Gauthier Bouche; Lydie Meheus; Vidula Sukhatme; Vikas P Sukhatme
Journal:  Ecancermedicalscience       Date:  2014-07-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.